These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 25682200)
1. Altered radiation responses of breast cancer cells resistant to hormonal therapy. Luzhna L; Lykkesfeldt AE; Kovalchuk O Oncotarget; 2015 Jan; 6(3):1678-94. PubMed ID: 25682200 [TBL] [Abstract][Full Text] [Related]
2. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. Lykkesfeldt AE; Madsen MW; Briand P Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264 [TBL] [Abstract][Full Text] [Related]
3. MCF7/LCC9: an antiestrogen-resistant MCF-7 variant in which acquired resistance to the steroidal antiestrogen ICI 182,780 confers an early cross-resistance to the nonsteroidal antiestrogen tamoxifen. Brünner N; Boysen B; Jirus S; Skaar TC; Holst-Hansen C; Lippman J; Frandsen T; Spang-Thomsen M; Fuqua SA; Clarke R Cancer Res; 1997 Aug; 57(16):3486-93. PubMed ID: 9270017 [TBL] [Abstract][Full Text] [Related]
4. Changes in DNA Damage Repair Gene Expression and Cell Cycle Gene Expression Do Not Explain Radioresistance in Tamoxifen-Resistant Breast Cancer. Post AEM; Bussink J; Sweep FCGJ; Span PN Oncol Res; 2020 Feb; 28(1):33-40. PubMed ID: 31046897 [TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy. Elias D; Vever H; Lænkholm AV; Gjerstorff MF; Yde CW; Lykkesfeldt AE; Ditzel HJ Oncogene; 2015 Apr; 34(15):1919-27. PubMed ID: 24882577 [TBL] [Abstract][Full Text] [Related]
6. Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells. Frankel LB; Lykkesfeldt AE; Hansen JB; Stenvang J Breast Cancer Res Treat; 2007 Aug; 104(2):165-79. PubMed ID: 17061041 [TBL] [Abstract][Full Text] [Related]
7. NFκB signaling is important for growth of antiestrogen resistant breast cancer cells. Yde CW; Emdal KB; Guerra B; Lykkesfeldt AE Breast Cancer Res Treat; 2012 Aug; 135(1):67-78. PubMed ID: 22527100 [TBL] [Abstract][Full Text] [Related]
8. Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro. Jordan NJ; Dutkowski CM; Barrow D; Mottram HJ; Hutcheson IR; Nicholson RI; Guichard SM; Gee JM Breast Cancer Res; 2014 Jan; 16(1):R12. PubMed ID: 24457069 [TBL] [Abstract][Full Text] [Related]
9. A suppressive role of guanine nucleotide-binding protein subunit beta-4 inhibited by DNA methylation in the growth of anti-estrogen resistant breast cancer cells. Wang B; Li D; Rodriguez-Juarez R; Farfus A; Storozynsky Q; Malach M; Carpenter E; Filkowski J; Lykkesfeldt AE; Kovalchuk O BMC Cancer; 2018 Aug; 18(1):817. PubMed ID: 30103729 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of STAT3 enhances sensitivity to tamoxifen in tamoxifen-resistant breast cancer cells. Moon SY; Lee H; Kim S; Hong JH; Chun SH; Lee HY; Kang K; Kim HS; Won HS; Ko YH BMC Cancer; 2021 Aug; 21(1):931. PubMed ID: 34407787 [TBL] [Abstract][Full Text] [Related]
11. Expression of the CD59 Glycoprotein Precursor is Upregulated in an Estrogen Receptor-alpha (ER-α)-Negative and a Tamoxifen-Resistant Breast Cancer Cell Line In Vitro. Xiong H; Jin X; You C Med Sci Monit; 2018 Nov; 24():7883-7890. PubMed ID: 30391994 [TBL] [Abstract][Full Text] [Related]
12. Tamoxifen-resistant fibroblast growth factor-transfected MCF-7 cells are cross-resistant in vivo to the antiestrogen ICI 182,780 and two aromatase inhibitors. McLeskey SW; Zhang L; El-Ashry D; Trock BJ; Lopez CA; Kharbanda S; Tobias CA; Lorant LA; Hannum RS; Dickson RB; Kern FG Clin Cancer Res; 1998 Mar; 4(3):697-711. PubMed ID: 9533540 [TBL] [Abstract][Full Text] [Related]
13. Changes in radiation sensitivity and steroid receptor content induced by hormonal agents and ionizing radiation in breast cancer cells in vitro. Paulsen GH; Strickert T; Marthinsen AB; Lundgren S Acta Oncol; 1996; 35(8):1011-9. PubMed ID: 9023387 [TBL] [Abstract][Full Text] [Related]
14. A kinase inhibitor screen identifies Mcl-1 and Aurora kinase A as novel treatment targets in antiestrogen-resistant breast cancer cells. Thrane S; Pedersen AM; Thomsen MB; Kirkegaard T; Rasmussen BB; Duun-Henriksen AK; Lænkholm AV; Bak M; Lykkesfeldt AE; Yde CW Oncogene; 2015 Aug; 34(32):4199-210. PubMed ID: 25362855 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of a pure steroidal antiestrogen with those of tamoxifen in a model of human breast cancer. Osborne CK; Coronado-Heinsohn EB; Hilsenbeck SG; McCue BL; Wakeling AE; McClelland RA; Manning DL; Nicholson RI J Natl Cancer Inst; 1995 May; 87(10):746-50. PubMed ID: 7563152 [TBL] [Abstract][Full Text] [Related]
16. Differential regulation of specific genes in MCF-7 and the ICI 182780-resistant cell line MCF-7/182R-6. Jensen BL; Skouv J; Lundholt BK; Lykkesfeldt AE Br J Cancer; 1999 Feb; 79(3-4):386-92. PubMed ID: 10027303 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of TMEM47 Induces Tamoxifen Resistance in Human Breast Cancer Cells. Men X; Su M; Ma J; Mou Y; Dai P; Chen C; Cheng XA Technol Cancer Res Treat; 2021; 20():15330338211004916. PubMed ID: 33745390 [TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator. Juncker-Jensen A; Lykkesfeldt AE; Worm J; Ralfkiaer U; Espelund U; Jepsen JS Growth Horm IGF Res; 2006 Aug; 16(4):224-39. PubMed ID: 16893667 [TBL] [Abstract][Full Text] [Related]
19. Aurora kinase B is important for antiestrogen resistant cell growth and a potential biomarker for tamoxifen resistant breast cancer. Larsen SL; Yde CW; Laenkholm AV; Rasmussen BB; Duun-Henriksen AK; Bak M; Lykkesfeldt AE; Kirkegaard T BMC Cancer; 2015 Apr; 15():239. PubMed ID: 25885472 [TBL] [Abstract][Full Text] [Related]
20. Resistance of human breast-cancer cells to the pure steroidal anti-estrogen ICI 182,780 is not associated with a general loss of estrogen-receptor expression or lack of estrogen responsiveness. Larsen SS; Madsen MW; Jensen BL; Lykkesfeldt AE Int J Cancer; 1997 Sep; 72(6):1129-36. PubMed ID: 9378550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]